Olkimmilo - Protein Synthesis Inhibitors - BW
Olkimmilo - Protein Synthesis Inhibitors - BW
Olkimmilo - Protein Synthesis Inhibitors - BW
Indications Rickettsial infections (rocky mountain spotted fever), TELITHR Effective against macrolide-resistant organisms
chlamydia, lyme disease, mycoplasmal infections, chronic OMYCIN
severe acne, cholera, gastric/duodenal ulcer caused by H. Indications: respiratory tract infections, including
pylori community-acquired bacteria pneumonia, acute
PK Excreted in bile, urine, breast milk, undergo enterohepatic exacerbations of chronic bronchitis, sinusitis and strepto
circulation pharyngitis
GI GI, deposition of drug in bones and teeth, liver failure, Indications: community acquired pneumonia (mycoplasma, legionella,
phototoxicity, vertigo, avoid in pregnant chlamydia), pertussis, campylobacter jejuni gastroenteritis, MAC
(azalides)
TETRACYCLINES
PK: Well distributed, CNS penetration limited except with inflammation.
SHORT CHLORTETRACYCLINE
Most of drug is concentrated in the liver and excreted in the bile, some
TETRACYCLINE inactivated in the liver by demethylation.
OXYTETRACYCLINE
AE: GI, jaundice, ototoxicity
INTERM DEMECLOCYCLINE treats SIADH
EDIATE
Bacteriostatic, bactericidal at high doses
METHACYCLINE
ERYTHROMYCIN MOA: Interferes with aminoacyl translocation, for which no alternative exists
STREPTOMYCIN 2nd line agent for the treatment of tuberculosis in SPECTIN Indications: alternative treatment for drug-resistant
combination with other agents to prevent emergence OMYCIN gonorrhea or gonorrhea in pcn-allergic pts
of resistance No cross-resistance with other drugs used in gonorrhea
AE: vestibular disturbances AE: pain at injection site, fever, nausea